Thomas Monica R.
Insider CIK 1978347 · GTHX General Counsel
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GTHX G1 Therapeutics, Inc. | D To issuer deriv | 2024-09-18 | 2024-09-18 | 55,875 | — | $0 | 0 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | D To issuer deriv | 2024-09-18 | 2024-09-18 | 150,000 | — | $0 | 0 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | U Tender | 2024-09-18 | 2024-09-18 | 6,674 | — | $0 | 0 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | D To issuer | 2024-09-18 | 2024-09-18 | 138,151 | — | $0 | 6,674 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award | 2024-07-01 | 2024-07-03 | 35,000 | — | $0 | 144,825 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | S Sale | 2024-05-23 | 2024-05-24 | 5,826 | $4.27 | $24.9K | 109,825 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award | 2024-03-20 | 2024-03-22 | 37,500 | — | $0 | 115,651 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award deriv | 2024-01-03 | 2024-01-08 | 55,875 | — | $0 | 55,875 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award | 2024-01-03 | 2024-01-08 | 27,975 | — | $0 | 78,151 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award deriv | 2023-05-22 | 2023-05-24 | 150,000 | — | $0 | 150,000 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award | 2023-05-22 | 2023-05-24 | 50,000 | — | $0 | 50,176 | SEC↗ |